Shivinder Singh1, Abhishek Bhardawaj2, Ratnesh Shukla3, Trimbak Jhadav4, Anoop Sharma5, D Basannar6. 1. Senior Adviser (Anaesthesiology & Critical Care), Command Hospital (Western Command), Chandimandir, India. 2. Graded Specialist (Anaesthesiology), 308 Field Hospital, C/O 56 APO, India. 3. Graded Specialist (Anaesthesiology), Military Hospital Babina, C/O 56 APO, India. 4. Graded Specialist (Anaesthesiology), Military Hospital Mathura, UP, India. 5. Graded Specialist (Anaesthesiology), INS Virat, C/O FMO Mumbai, India. 6. Scientist 'E', Department of Community Medicine, Armed Forces Medical College, Pune 411040, India.
Abstract
BACKGROUND: This study was done to compare the accuracy of the Lactate Pro LT 1710 (Arkray Inc., Kyoto, Japan) with the Combiline Plus (Eschweiler GmbH & Co. KG Holzkoppelweg, Kiel, Germany), and also, to analyze the prognostic significance of serum lactates and Simplified Acute Physiology Score 3 (SAPS 3) in patients of severe sepsis. METHODS: 106 patients of severe sepsis admitted to the ICU were screened. The serum lactate from an arterial sample analyzed in both the machines was recorded at admission and at 48 h. These patients were then followed up to the 28th day for mortality. RESULTS: The Lactate Pro LT 1710 handheld point of care lactate meter provides consistent results comparable to the Eschweiler Combiline blood gas analyser. Serum lactate concentration was significantly higher in nonsurvivors at the time of admission (3.30 ± 1.26) and at 48 h (4.34 ± 1.73). Lactate clearance at 48 h appears to be a better predictor of mortality than the lactate levels at 0 h and 48 h. The mean SAPS 3 at admission amongst survivors was significantly less as compared to nonsurvivors. The SAPS 3 had improved to 47.44 (±11.79) in survivors at 48 h, while in nonsurvivors it had worsened to 81.98 (±12.32) (p = 0.00); thus, a worsening SAPS 3 at 48 h had a poorer prognosis. CONCLUSIONS: The Lactate Pro LT 1710 provides similar results to the Combiline Eschweiler blood gas analyser and is a cheaper alternative. It would prove to be a boon in peripheral hospitals in the aggressive management of critically ill patients.
BACKGROUND: This study was done to compare the accuracy of the Lactate Pro LT 1710 (Arkray Inc., Kyoto, Japan) with the Combiline Plus (Eschweiler GmbH & Co. KG Holzkoppelweg, Kiel, Germany), and also, to analyze the prognostic significance of serum lactates and Simplified Acute Physiology Score 3 (SAPS 3) in patients of severe sepsis. METHODS: 106 patients of severe sepsis admitted to the ICU were screened. The serum lactate from an arterial sample analyzed in both the machines was recorded at admission and at 48 h. These patients were then followed up to the 28th day for mortality. RESULTS: The Lactate Pro LT 1710 handheld point of care lactate meter provides consistent results comparable to the Eschweiler Combiline blood gas analyser. Serum lactate concentration was significantly higher in nonsurvivors at the time of admission (3.30 ± 1.26) and at 48 h (4.34 ± 1.73). Lactate clearance at 48 h appears to be a better predictor of mortality than the lactate levels at 0 h and 48 h. The mean SAPS 3 at admission amongst survivors was significantly less as compared to nonsurvivors. The SAPS 3 had improved to 47.44 (±11.79) in survivors at 48 h, while in nonsurvivors it had worsened to 81.98 (±12.32) (p = 0.00); thus, a worsening SAPS 3 at 48 h had a poorer prognosis. CONCLUSIONS: The Lactate Pro LT 1710 provides similar results to the Combiline Eschweiler blood gas analyser and is a cheaper alternative. It would prove to be a boon in peripheral hospitals in the aggressive management of critically illpatients.
Entities:
Keywords:
Lactate Pro; SAPS 3; Serum lactate; Severe sepsis
Authors: Mitchell M Levy; William L Macias; Jean-Louis Vincent; James A Russell; Eliezer Silva; Benjamin Trzaskoma; Mark D Williams Journal: Crit Care Med Date: 2005-10 Impact factor: 7.598
Authors: Jean-Louis Vincent; Yasser Sakr; Charles L Sprung; V Marco Ranieri; Konrad Reinhart; Herwig Gerlach; Rui Moreno; Jean Carlet; Jean-Roger Le Gall; Didier Payen Journal: Crit Care Med Date: 2006-02 Impact factor: 7.598
Authors: Tim C Jansen; Jasper van Bommel; F Jeanette Schoonderbeek; Steven J Sleeswijk Visser; Johan M van der Klooster; Alex P Lima; Sten P Willemsen; Jan Bakker Journal: Am J Respir Crit Care Med Date: 2010-05-12 Impact factor: 21.405
Authors: R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno Journal: Intensive Care Med Date: 2013-01-30 Impact factor: 17.440
Authors: Tim C Jansen; Jasper van Bommel; Paul G Mulder; Johannes H Rommes; Selma J M Schieveld; Jan Bakker Journal: Crit Care Date: 2008-12-17 Impact factor: 9.097